Pinnacle Medicines, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Pinnacle Medicines, Inc. - overview
Established
2024
Location
Doylestown, PA, US
Primary Industry
Biotechnology
About
Founded in 2024 and based in Pennsylvania, US, Pinnacle Medicines, Inc. operates as a biotechnology company that provides oral peptide drug discovery and development services for immunology and cardiometabolic diseases.
Current Investors
OrbiMed Advisors, Lilly Asia Ventures, Foresite Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.pinnaclemedicines.com
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.